Amarantus Bioscience Holdings, Inc.
Pharmaceutical company · San Francisco, California, United States
Amarantus Bioscience Holdings, Inc. is a pharmaceutical company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2013. It has reported private securities offerings to the US SEC, most recently $300,000 sold in a notice filed in 2018.
Amarantus Bioscience Holdings at a glance
What does Amarantus Bioscience Holdings do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $300,000 sold (2018).
Frequently asked questions about Amarantus Bioscience Holdings
Where is Amarantus Bioscience Holdings headquartered?
Amarantus Bioscience Holdings, Inc. is headquartered in San Francisco, California, United States.
What does Amarantus Bioscience Holdings do?
Amarantus Bioscience Holdings, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Amarantus Bioscience Holdings founded?
The earliest incorporation on record for Amarantus Bioscience Holdings, Inc. is in 2013, according to public company registers.
Similar companies
- Kyntra Bio, Inc.San Francisco, California, United States
- Nektar TherapeuticsSan Francisco, California, United States
- Olema Pharmaceuticals, Inc.San Francisco, California, United States
- GT Biopharma, Inc.San Francisco, California, United States
- Delpor, Inc.San Francisco, California, United States
- Jaguar Health, Inc.San Francisco, California, United States
- Silver Creek Pharmaceuticals, Inc.San Francisco, California, United States
- Napo Pharmaceuticals IncSan Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences